The NHS is about to start doling out ‘the King Kong of weight loss drugs’ to obese patients – the scandal, needless to say, is that not enough people will qualify. The drug, Mounjaro, will be limited to people with a Body Mass Index (BMI) of over 35 and who have at least one medical condition resulting from their excess weight.
Already a subscriber? Log in
Subscribe for just $2 a week
Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in